Effect of rilalutide combined with metformin in the treatment of diabetes
利拉鲁肽联合二甲双胍治疗糖尿病的效果

摘要

目的 研究利拉鲁肽联合二甲双胍对于治疗糖尿病的效果。方法 选取我院80例糖尿病患者作为本次研究对象，按计算机表法将其分为2组（对照组、实验组）。对照组患者服用二甲双胍治疗，实验组患者在对照组基础上联合利拉鲁肽治疗，将两组临床治疗效果、不良反应发生情况、相关血糖指标水平以及脂肪因子水平进行比较。结果 实验组临床治疗总有效率高于对照组，不良反应发生率低于对照组，实验组患者相关血糖指标水平以及脂肪因子水平优于对照组，组间有差异，P＜0.05。结论 对于糖尿病患者而言，利拉鲁肽联合二甲双胍效果显著，减少不良反应发生，用药安全性较高，改善相关指标，具有推广价值。

Abstract

Objective: To study the effect of rilalutide combined with metformin in the treatment of diabetes.
Methods: 80 patients with diabetes in our hospital were selected as the subjects of this study and divided into two groups (control group and experimental group) according to the computer table method. The patients in the control group were treated with metformin, while the patients in the experimental group were treated with liraglutide on the basis of the control group. The clinical treatment effect, adverse reactions, related blood glucose index levels, and adipose factor levels of the two groups were compared.
Results: The total effective rate of clinical treatment in the experimental group was higher than that in the control group, and the incidence of adverse reactions was lower than that in the control group. The levels of related blood glucose indicators and adipose factors in the experimental group were better than those in the control group, with differences between the groups (P<0.05).
Conclusion  : For patients with diabetes, the combination of rilalutide and metformin has a significant effect, reduces the occurrence of adverse reactions, has high drug safety, improves relevant indicators, and is worth popularizing.